Sanofi-aventis and Scripps Genomic Medicine, a division of Scripps Health, announced today a strategic alliance to advance research and development initiatives in the fie...
Sanofi-aventis and Scripps Genomic Medicine, a division of Scripps Health, announced today a strategic alliance to advance research and development initiatives in the fie...
Sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration has approved a new one-vial formulation of its chemotherapeutic agent Taxotere® Injection...
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group , announced today that shipping of the 2010-2011 formulation of its seasonal influenza vaccine Fluzone® ...
Sanofi-Aventis Deutschland GmbH and Novalar Pharmaceuticals, Inc. today announced that the Marketing Authorization Application for OraVerse has been accepted for review ...
The IBTAnnouncement Service helps investors discover the latest information reported by companies in which they are invested, including changes in voting rights, net asset values, and more.